Modern concept of neuroendocrine and epigenetic regulation of the onset of puberty and sexual development. Translational studies on the role of the KISS/KISS1R system
https://doi.org/10.18705/2311-4495-2020-7-5-62-80
Abstract
About the Authors
I. L. NikitinaRussian Federation
Nikitina Irina L., MD, PhD, Head of Research Laboratory of Pediatric Endocrinology at Institute of Endocrinology, Head of the Department of Childhood Diseases, Institute of Medical Education
Akkuratova str. 2, Saint Petersburg, 197341
Y. N. Yuchlina
Russian Federation
Yuchlina Yulia N., Assistant at the Department of Childhood Diseases, Institute of Medical Education
Saint Petersburg
L. R. Sarakaeva
Russian Federation
Sarakaeva Leyla R., Junior Researcher at Research Laboratory of Pediatric Endocrinology at Institute of Endocrinology
Saint Petersburg
A. O. Plaksina
Russian Federation
Plaksina Anna O., Senior Laboratory Assistant, Department of Childhood Diseases, Institute of Medical Education
Saint Petersburg
A. A. Bayramov
Russian Federation
Bayramov Alekber A., MD, PhD, Leading Researcher, Research Laboratory of Clinical Endocrinology, Institute of Endocrinology
Saint Petersburg
References
1. Abreu AP, Kaiser UB. Pubertal development and regulation. Lancet Diabetes Endocrinol. 2016; 4 (3): 254–264.
2. Ojeda SR, Lomniczi A, Sandau U, et al. New concepts on the control of the onset of puberty. In: Loche S, Cappa M, Ghizzoni L, et al., eds. Pediatric Neuroendocrinology. Endocr Dev. Basel, Karger, 2010; 17: 44–51.
3. Ojeda SR, Terasawa E. Neuroendocrine regulation of puberty. In: Pfaff D, Arnold A, Etgen A, et al., eds. Hormones, Brain and Behavior. New York, Elsevier, 2002; 4: 589–659.
4. Lomniczi A, Ojeda SR. The emerging role of epigenetics in the regulation of female puberty. In: Bourguignon J-P, Parent A-S, eds. Puberty from bench to clinic. Lessons for clinical management of pubertal disorders. Endocr Dev. Basel, Karger, 2016; 29: 1–16.
5. Ranke MB, Mullis P-E, eds. Diagnostics of endocrine function in children and adolescents. 4th, rev and extended ed. Basel, Karger, 2011:535.
6. Willemsen RH, Dunger DB. Normal variations in pubertal timing: genetic determinants in relation to growth and adiposity. In: Bourguignon J-P, Parent A-S, eds. Puberty from bench to clinic. Lessons for clinical management of pubertal disorders. Endocr Dev. Basel, Karger. 2016; 29: 17–35.
7. Topaloglu AK, Reimann F, Guclu М, et al. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat Genet. 2009; 41 (3): 354–358.
8. Leon S, Barroso A, Vazguez MJ, et al. Direct actions of kisspeptins on GnRH neurons permit attainment of fertility but are insufficient to fully preserve gonadotropic axis activity. Sci Rep. 2016; 6: 19206.
9. Brown RE, Imran SА, Ur E, et al. KiSS–1 mRNA in adipose tissue is regulated by sex hormones and food intake. Mol Cell Endocrinol. 2008; 281 (1–2): 64–72.
10. Tng EL. Kisspeptin signalling and its roles in humans. Singapore Med J. 2015; 56 (12): 649–656.
11. Celik O, Celik N, Aydin S, et al. Ghrelin action on GnRH neurons and pituitary gonadotropes might be mediated by GnIH-GPR147 system. Horm Mol Biol Clin Investig. 2016; 25 (2): 121–128.
12. Javed Z, Qamar U, Sathyapalan T. The role of kisspeptin signalling in the hypothalamic-pituitary-gonadal axis - current perspective. Endokrynol Pol. 2015; 66 (6): 534–547.
13. Tena-Sempere M. Kisspeptin signaling in the brain: recent developments and future challenges. Mol Cell Endocrinol. 2010; 314 (2): 164–169.
14. Sapronov NS. Gonadoliberins. SPb.: Art-express, 2012. p. 272. In Russian
15. Pinilla L, Aguilar E, Dieguez C, et al. Kisspeptins and reproduction: physiological roles and regulatory mechanisms. Physiol Rev. 2012; 92 (3): 1235–1316.
16. Guerriero KA, Keen KL, Millar RP, et al. Developmental changes in GnRH release in response to kisspeptin agonist and antagonist in female rhesus monkeys (Macaca mulatta): implication for the mechanism of puberty. Endocrinology. 2012; 153 (2): 825–836.
17. Roseweir AK, Kauffman AS, Smith JT, et al. Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation. J Neurosci. 2009; 29 (12): 3920–3929.
18. George JT, Veldhuis JD, Roseweir AK, et al. Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. J Clin Endocrinol Metab. 2011; 96 (8): E1228–1236.
19. Newton CL, Anderson RC, Millar RP. Therapeutic neuroendocrine agonist and antagonist analogs of hypothalamic neuropeptides as modulators of the hypothalamic-pituitary-gonadal axis. Endocr Dev. 2016; 30: 106–129.
20. Yarmolinskay MI, Ganbarli NF, Aylamazyan EK. Role of kisspeptine in regulation of reproductive function. ZHurnal akusherstva i zhenskih boleznej= Journal of Obstetrics and Women’s Diseases. 2016; 65 (6): 4–18. In Russian
21. George JT, Veldhuis JD, Roseweir AK, et al. Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. J Clin Endocrinol Metab. 2011; 96 (8): E1228–1236.
22. Chan YM, Butler JP, Pinnell NE, et al. Kisspeptin resets the hypothalamic GnRH clock in men. J Clin Endocrinol Metab. 2011; 96 (6): 908–915.
23. Jayasena CN, Abbara A, Narayanaswamy S, et al. Direct comparison of the effects of intravenous kisspeptin-10, kisspeptin-54 and GnRH on gonadotrophin secretion in healthy men. Hum Reprod. 2015; 30 (8): 19341941.
24. Matsui H, Takatsu Y, Kumano S, et al. Peripheral administration of metastin induces marked gonadotropin release and ovulation in the rat. Biochem Biophys Res Commun. 2004; 320 (2): 383–388.
25. Dhillo WS, Chaudhri OB, Patterson M, et al. Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab 2005; 90 (12): 6609–6615.
26. George JT, Veldhuis JD, Roseweir AK, et al. Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men. J Clin Endocrinol Metab. 2011; 96 (8): 1228–1236.
27. Young J, George JT, Tello JA, et al. Kisspeptin restores pulsatile LH secretion in patients with neurokinin B signaling deficiencies: physiological, pathophysiological and therapeutic implications. Neuroendocrinology. 2013; 97 (2): 193–202.
28. Nikitina IL, Khoduleva YuN, Masel AS, et al. System of KISS-KISS1R: focus on peripheral signaling in androgen-dependent tissues in the experimentally induced model hypogonadotropic hypogonadism. Patologicheskaya fiziologiya i eksperimental’naya terapiya=Patological physiology and experimental therapy. 2016; 60 (4): 24–33. In Russian
29. Nikitina IL, Bayramov AA, Khoduleva YuN, et al. Kisspeptins in physiology and pathology of sex development — new diagnostic and therapeutic approaches. Obzory po klinicheskoj farmakologii i lekarstvennoj terapii=Reviews on clinical pharmacology and drug therapy. 2014; 12 (4): 3–12. In Russian
30. Nikitina IL. The timing of puberty: well-known and new. Arterial’naya gipertenziya=Arterial hypertension. 2013; 19 (3): 227–236. In Russian
31. Nikitina IL, Yuchlina YN, Vasileva EY, et al. Kisspeptin regulation of male sex development: possibilities of diagnosis and treatment of delayed puberty and hypogonadotropic hypogonadism. Problemy endocrinologii=Problems of endocrinology. 2018; 64 (5): 280–285. In Russian
32. Droblenkov AV, Proshina LG, Yuhlina YuN, et al. Testosterone-dependent changes in neurons of hypothalamic arcuate nucleus and reversibility of these changes by modeled male hypogonadism. Patologicheskaya fiziologiya i eksperimental’naya terapiya=Patological physiology and experimental therapy. 2017; 61 (4): 21–30. In Russian
Review
For citations:
Nikitina I.L., Yuchlina Y.N., Sarakaeva L.R., Plaksina A.O., Bayramov A.A. Modern concept of neuroendocrine and epigenetic regulation of the onset of puberty and sexual development. Translational studies on the role of the KISS/KISS1R system. Translational Medicine. 2020;7(5):62-80. (In Russ.) https://doi.org/10.18705/2311-4495-2020-7-5-62-80